Company: FENC
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001558370-25-005563
Chunk: 27

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 27
---
2024, Mr. Hackman was granted 400,000 options with a strike price of $5.58. In May of 2024, Mr. Raykov was granted 200,000 options with a strike price of $7.12 and 100,000 RSU’s. In March of 2024, Mr. Andrade was granted 100,000 options with a strike price of $7.12 and 50,000 RSU’s. In November of 2024, Mr. Sayad was granted 150,000 options with a strike price of $4.23. Compensation Committee Report The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis contained in this Circular with management and, based on that review and discussion, the Compensation Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Circular.

| ​             | ​                                                    |
| Submitted by: | THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS |
| ​             | Dr. Marco Brughera, Chair                            |
| ​             | Chris Rallis                                         |
| ​             | Dr. Jodi Cook                                        |

Page17

Compensation Committee Interlocks and Insider Participation Dr. Marco Brughera, Chris Rallis, and Dr. Jodi Cook are the current members of the Compensation Committee. None of these individuals were at any time during 2024 or at any other time an officer or employee of ours. No interlocking relationship exists between any member of our Compensation Committee and any member of any other company’s board of directors or compensation committee. The Board has determined that each member of the Compensation Committee is “independent” under applicable securities laws.

Pay Versus Performance

As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive compensation actually paid and certain financial performance of the Corporation.

The following information is presented to disclose the relationship between executive “compensation actually paid” or CAP, as calculated under applicable SEC rules, and the Corporation’s financial performance. As required by SEC rules, the table presented below discloses CAP for (i) the Corporation’s principal executive officer (“PEO”), Mr. Hackman and the former principal executive officer (“Former PEO”) Mr. Raykov, and (ii) the Corporation’s NEOs other than Mr. Hackman and Mr. Raykov (collectively, “Non-